These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 3103510)
1. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Petri M; Rheinschmidt M; Whiting-O'Keefe Q; Hellmann D; Corash L Ann Intern Med; 1987 Apr; 106(4):524-31. PubMed ID: 3103510 [TBL] [Abstract][Full Text] [Related]
2. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Petri M; Golbus M; Anderson R; Whiting-O'Keefe Q; Corash L; Hellmann D Arthritis Rheum; 1987 Jun; 30(6):601-6. PubMed ID: 3111489 [TBL] [Abstract][Full Text] [Related]
3. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518 [TBL] [Abstract][Full Text] [Related]
5. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus. Ferro D; Saliola M; Quintarelli C; Valesini G; Basili S; Grandilli AM; Bonavita MS; Violi F J Clin Pathol; 1992 Apr; 45(4):332-8. PubMed ID: 1577971 [TBL] [Abstract][Full Text] [Related]
6. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times. Alving BM; Barr CF; Tang DB Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643 [TBL] [Abstract][Full Text] [Related]
7. Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. Out HJ; van Vliet M; de Groot PG; Derksen RH Ann Rheum Dis; 1992 Mar; 51(3):353-7. PubMed ID: 1575581 [TBL] [Abstract][Full Text] [Related]
8. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant. Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274 [TBL] [Abstract][Full Text] [Related]
9. Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus. Ferro D; Saliola M; Quintarelli C; Carlucci M; Valesini G; Violi F Thromb Res; 1990 Aug; 59(3):609-17. PubMed ID: 2122546 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Rote NS; Dostal-Johnson D; Branch DW Am J Obstet Gynecol; 1990 Aug; 163(2):575-84. PubMed ID: 2117391 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Love PE; Santoro SA Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431 [TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy. Pattison NS; McKay EJ; Liggins GC; Lubbe WF N Z Med J; 1987 Feb; 100(817):61-4. PubMed ID: 3103033 [TBL] [Abstract][Full Text] [Related]
13. The automated modified Russell viper venom time test for the lupus anticoagulant. Petri M; Nelson L; Weimer F; Anderson D; Darlington T; Corash L J Rheumatol; 1991 Dec; 18(12):1823-5. PubMed ID: 1795319 [TBL] [Abstract][Full Text] [Related]
14. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043 [TBL] [Abstract][Full Text] [Related]
15. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies. Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611 [TBL] [Abstract][Full Text] [Related]
16. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. Creagh MD; Malia RG; Cooper SM; Smith AR; Duncan SL; Greaves M J Clin Pathol; 1991 Jan; 44(1):45-7. PubMed ID: 1900070 [TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722 [TBL] [Abstract][Full Text] [Related]
18. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus. Sukenik S; el-Roeiy A; Shoenfeld Y Acta Haematol; 1986; 76(2-3):86-9. PubMed ID: 3101368 [TBL] [Abstract][Full Text] [Related]
19. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904 [TBL] [Abstract][Full Text] [Related]
20. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Derksen RH; Hasselaar P; Blokzijl L; Gmelig Meyling FH; De Groot PG Ann Rheum Dis; 1988 May; 47(5):364-71. PubMed ID: 3133992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]